Go to the list of all blogs
Dem Sem's Avatar
published in Blogs
Dec 28, 2023
$AWH, $AGRX, $RDUS Propel Women's Health Sector with Remarkable +14.83% Weekly Performance Surge

$AWH, $AGRX, $RDUS Propel Women's Health Sector with Remarkable +14.83% Weekly Performance Surge

Robots for this group tickers :
Day Trader, Popular Stocks: Price Action Trading Strategy (TA&FA) - 30-day Annualized Return +209%
Swing Trader, Popular Stocks: Price Action Trading Strategy - Pro Version (TA&FA) - 30-day Annualized Return +182%

Recently, Women's Health companies have taken center stage, showcasing a remarkable +14.83% increase in performance over the past week. This surge is backed by three key players in the sector - AWH (Aspira Women's Health), AGRX (Agile Therapeutics), and RDUS (Radius Health).

Positive Outlook and Volume Indicators: Today, stocks in the Women's Health group maintain a positive outlook, supported by robust Volume Indicators. Tickeron, a leading market analysis platform, predicts a further increase of over 4.00% within the next month, with a 63% likelihood. The daily ratio of advancing to declining volumes in the past month was an impressive 4.35 to 1.

Advances Indicator and Positive Trends: A closer look at the Advances Indicator reveals a consistent positive trend across three stocks in this thematic group, with an average likelihood of 82%. This suggests a prevailing sentiment of growth and stability among investors.

Market Capitalization Insights: The market capitalization within the Women's Health Theme averages at 245.7M. RDUS stands out with the highest valuation in this group, reaching an impressive 697.4M. In contrast, AGRX holds the position of the lowest valued company at 5.2M.

Price Movements: Weekly, the average price growth for all stocks in the Women's Health Theme was a significant 14.83%. AWH spearheaded this growth with a remarkable 43.89% increase, while AGRX experienced a notable dip at -2.99%. The monthly and quarterly averages stood at 10.55% and -4.59%, respectively.

Notable News and Price Movements:

  • AWH made headlines as the top weekly gainer, rising by 26.79% on 8/15/23, and also faced a significant drop of -36.68% on 7/27/23.
  • AGRX, on 10/7/23, saw a sharp decline of -20.83%, marking it as a top weekly loser.
  • RDUS, on 12/26/23, continued an uptrend, experiencing a +22% increase during the month of 11/22/23 - 12/26/23.

Volume Growth: While the average weekly volume growth across all stocks in the Women's Health Theme was -1.08%, monthly and quarterly figures painted a different picture with 164.37% and 19.64% growth, respectively. Notable record-breaking daily volume increases were observed for AWH, AGRX, and RDUS, emphasizing heightened market activity.

Technical Analysis Highlights:

  1. AWH: The 50-day moving average crossed bearishly below the 200-day moving average on December 11, 2023. Despite this, the stock has shown resilience, with a recent uptrend of +28% during the week of 12/18/23 - 12/26/23.

  2. AGRX: The RSI Oscillator for AGRX moved out of the overbought zone on December 05, 2023, suggesting a potential shift from an upward to a downward trend. The odds of a move down, according to Tickeron's analysis, stand at 90%.

  3. RDUS: Displaying a +1.52% uptrend, RDUS advanced for three consecutive days on December 26, 2023. Historical data indicates a 75% likelihood of continued upward momentum.

Summary: The Women's Health sector, led by AWH, AGRX, and RDUS, is currently in a phase of dynamic growth, supported by positive market indicators and technical analyses. Investors should keep a keen eye on these stocks, considering the theme's potential for further expansion in the coming months.

Related Ticker: AWHL, AGRX, RDUS

Contributor

Dem Sem's AvatarDem Sem|Expert

View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a company, which engages in the provision of bio-analytic and diagnostic services and helps physicians diagnose, treat, and improve gynecologic health outcomes for women

Industry MedicalSpecialties

Profile
Details
Industry
Multi Line Insurance
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Interact to see
Advertisement
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Intercontinental Exchange (ICE) has navigated recent market volatility while remaining within its 52-week range. Broader weakness in financial data and exchange operators has created short-term pressure, but ICE’s diversified business model continues to provide stability.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
$AWH, $AGRX, $RDUS Propel Women's Health Sector with Remarkable +14.83% Weekly Performance Surge